Molecular imaging and neural networks in impulse control disorders in Parkinson's disease

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1(Suppl 1):S101-5. doi: 10.1016/j.parkreldis.2015.08.003. Epub 2015 Aug 12.

Abstract

Impulse control disorders (ICDs) may arise in Parkinson's disease (PD) in relation to the use of dopamine agonists (DA). A dysfunction of reward circuits is considered the main underlying mechanism. Neuroimaging has been largely used in this setting to understand the structure of the reward system and its abnormalities brought by exogenous stimulation in PD. Dopaminergic changes, such as increased dopamine release, reduced dopamine transporter activity and other changes, have been shown to be a consistent feature of ICDs in PD. Beyond the striatum, alterations of prefrontal cortical function may also impact an individuals' propensity for impulsivity. Neuroimaging is advancing our knowledge of the mechanisms involved in the development of these behavioral addictions. An increased understanding of these disorders may lead to the discovery of new therapeutic targets, or the identification of risk factors for the development of these disorders.

Keywords: Impulse control disorders; Molecular imaging; Parkinson's disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Corpus Striatum / metabolism
  • Corpus Striatum / pathology
  • Disruptive, Impulse Control, and Conduct Disorders / chemically induced
  • Disruptive, Impulse Control, and Conduct Disorders / diagnosis*
  • Disruptive, Impulse Control, and Conduct Disorders / metabolism*
  • Dopamine / metabolism
  • Dopamine Agonists / adverse effects
  • Humans
  • Molecular Imaging / methods*
  • Nerve Net / metabolism*
  • Nerve Net / pathology
  • Neuroimaging / methods
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / metabolism*

Substances

  • Dopamine Agonists
  • Dopamine